Short answer
Inmune Bio, Inc. (INMB) filed an 8-K current report with the SEC on July 1, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement). Warrant exercise price cut to $1.40 from $1.95 for 647,112 warrants.
Inmune Bio, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Warrant exercise price cut to $1.40 from $1.95 for 647,112 warrants
- Expected gross proceeds of $905,957 from cash exercises
- Remaining 50% of affected warrants extended to December 31, 2027 from June 30, 2026
- Transaction accelerates cash funding but increases potential future share dilution
- Shares underlying warrants covered by effective registration statement facilitating issuance or resale
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Inmune Bio, Inc. 8-K filings
Get the next INMB 8-K as it lands
Follow INMB for push alerts, or ask the research agent what this filing means.